Corporate
Disc Medicine Defends Path Forward After FDA Rejects Bitopertin in Rare Disease Setback
Feb 17
You're signed outSign in or to get full access.
DM
Disc Medicine (IRON)·Earnings Reports
Q3 2025
View earnings summary and analysis
Q4 2024
View earnings summary and analysis
Q3 2024
View earnings summary and analysis
Q2 2024
View earnings summary and analysis
Research analysts covering Disc Medicine.